1. MARKETS
  2. SECTOR : BANKING & FINANCE
  3. INDUSTRY : FINANCIAL CONGLOMERATES
  4. TEVOGEN BIO HOLDINGS INC.
Tevogen Bio Holdings Inc.
XNAS: TVGN
Download real time
7.07-0.01(-0.14%)
81.87% Fall from 52W High
2,304
XNAS Volume

XNAS 16 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Tevogen Bio Holdings Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Tevogen Bio Holdings Inc quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
  • NEUTRAL

    Quarterly Revenue Tevogen Bio Holdings Inc Jun-2026 Quarterly Revenue is $0 Million which is growth of 0% YoY.

  • NEGATIVE

    Quarterly Net Profit Tevogen Bio Holdings Inc Jun-2026 Quarterly Net Profit is $-6 Million which is growth of -4.7% YoY.

Tevogen Bio Holdings Inc., Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
Cost Of Rev.
-------------
Gross Profit
-------------
⌄
5.75.44.65.75.410.49.46.18.629.5-4.62.32.2
Operating Profit
-5.7-5.4-4.6-5.7-5.4-10.4-9.4-6.1-8.6-29.54.6-2.3-2.2
⌄
-0.1-0.1-0.1-0.1-0-0-0-0-0.20.6-0.3-0.3
Profit Before Tax
-5.8-5.5-4.7-5.7-5.5-10.4-9.5-5.9-9.711.356.8-3.9-22.2
Tax
-------------
⌄
-5.8-5.5-4.3-5.9-5.6-10.4-12.9-5.9-6.110.556.8-3.9-22.2
Diluted NI Avail to Com Stockholders Ann.
-5.8-5.6-4.3-5.9-5.6-10.5-12.9-5.9-6.1-37.856.8-3.9-22.2
Basic EPS
-1.5-1.6-2.1-1.5-1.5-3.5-3-1.5-2423.7-1.6-9.2
Diluted EPS After ExtraOrdinary
-1.5-1.6-2.1-1.5-1.5-3.5-3-1.6-1.7-1117.4-1.2-7
Number Of Shares End
3.83.543.93.73.22.13.43.12.82.42.42.4
Net Income Continuing Discontinued Operations
-5.8-5.5-4.7-5.7-5.5-10.4-9.4-5.9-9.711.356.8-3.9-22.2
Normalized Income
-2.5-2.61.5-2.6-2.2-3.1-0.4-2.8-4.53857-3.9-22.2
Interest Income
-------------
Interest
-0.10.10.1-000-0.2-0.60.30.3
Net Interest Income
-0.1-0.1-0.1-0.1-0-0-0-0-0.20.6-0.3-0.3
EBIT
-5.7-5.4-4.6-5.7-5.5-10.3-9.5-5.9-9.711.456.2-3.6-21.9
EBITDA
-5.6-5.3-4.5-5.4-5.4-10.2-9.4-5.7-9.711.556.2-3.4-21.9
Reconciled Cost Of Rev.
-------------
Reconciled Depr.
0.10.10.10.300.10.10.2-00.1-0.2-0
Profit From Continuing Operations
-5.8-5.5-4.7-5.7-5.5-10.4-9.4-5.9-9.711.356.8-3.9-22.2
Normalized EBITDA
-5.6-5.3-4.5-5.4-5.4-10.3-9.3-5.9-7.519.153.7-3.4-2.2
*All financials are in USD Million and price data in USD
Add metric to table
Search...

Tevogen Bio Holdings Inc competitor comparison and performance snapshot within industry

Tevogen Bio Holdings Inc annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEUTRAL

    Annual Revenue Tevogen Bio Holdings Inc Annual Revenue is $0 Million which is growth of 0% YoY.

  • NEGATIVE

    Annual Net Profit Tevogen Bio Holdings Inc Annual Net Profit is $-26 Million which is growth of -91.4% YoY.

Tevogen Bio Holdings Inc., Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21
⌄
-
 
Cost Of Rev. Ann.
-
 -----
Gross Profit Ann.
-
 -----
Operating Exp. Ann.
24%
21.426.153.62.313.74.6
Operating Profit Ann.
-
-21.4-26.1-53.6-2.3-13.7-4.6
⌄
-
-0.3-0.2-0.2-0.3-0.9-0.6
Other Exp. Ann.
-
 0.1402.5-7.4-10.4
PBT Ann.
-
-21.6-26.3-13.7-0.1-22-15.6
Tax Ann.
-
 -----
⌄
-
-21.4-26.3-13.7-0.1-22-15.6
Diluted NI Avail to Com Stockholders Ann.
-
-21.6-26.3-13.7-0.1-22-15.6
EPS Ann.
-
 -8.1-3.5-0-9.2-6.5
Diluted EPS Ann.
-
 -8.1-3.5-0-9.2-6.5
Number Of Shares End
-
 42.12.4--
Total Exp. Ann.
24%
 26.153.62.313.74.6
Net Income Continuing Discontinued Operations Ann.
-
-21.6-26.3-13.7-0.1-22-15.6
Normalized Income Ann.
-
-6.2-10.135.5-2.5-17.5-15
Interest Income Ann.
-
 -----
Interest Ann.
-39.4%
 0.20.20.30.90.6
EBITDA Ann.
-
-20.8-25.6-13.10.2-20.9-15
Reconciled Cost Of Rev. Ann.
-
 -----
Reconciled Depr. Ann.
35.7%
0.50.50.4-0.20
Profit From Continuing Operations Ann.
-
-21.6-26.3-13.7-0.1-22-15.6
Normalized EBITDA Ann.
-
-20.9-25.6-4.7-2.3-20.9-15
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Operating Exp. Ann.
1Y CHG
-51.3%
2Y CAGR
236.9%
3Y CAGR
24%

Tevogen Bio Holdings Inc balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Total Shareholders Fund Tevogen Bio Holdings Inc Dec-2025 Total Shareholders Fund is $-17 Million which is growth of -10.1% YoY.

  • POSITIVE

    Total Assets Tevogen Bio Holdings Inc Dec-2025 Total Assets is $4 Million which is growth of 26.6% YoY.

Tevogen Bio Holdings Inc., Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsDec '25Dec '24Dec '23Dec '22Dec '21
⌄
-17%
4.43.5177.77.7
⌄
-32.9%
12.610.117.741.724.2
⌄
-
-17-15.5-0.7-34-16.5
Total Capitalization Ann.
-
-3.8-5.7-0.75.47
Tangible Assets Ann.
-
-8.2-6.7-0.7-34-16.5
Working Capital Ann.
-
-5.5-6.7-2.73.96.5
Invested Capital Ann.
-
-11-12.80.95.47
Tangible Book Value Ann.
-
-17-15.5-0.7-34-16.5
Borrowings Ann.
-42.8%
7.52.91.64023.5
Net Debt Ann.
-45.4%
5.51.41.633.816.4
Share Issued Ann.
7.7%
43.63.33.23.2
Number Of Shares End
-
42.12.4--
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Assets Ann.
1Y CHG
25.7%
2Y CAGR
-49.1%
3Y CAGR
-17%
Total Current Liabilities Ann.
1Y CHG
-21.1%
2Y CAGR
53.8%
3Y CAGR
52.5%

Tevogen Bio Holdings Inc ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Book Value Per Share Tevogen Bio Holdings Inc Book Value Per Share is $-4 which is growth of -13.0% YoY.

  • NEUTRAL

    ROE Tevogen Bio Holdings Inc ROE is 0% which is growth of 0% YoY.

Tevogen Bio Holdings Inc., Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsDec '25Dec '24Dec '23Dec '22Dec '21
RoA Ann. %
-
--133.93%-0.54%-286.30%-203.66%
ROE Ann. %
-
-----
ROIC %
-
-----
OPM Ann. %
-
-----
Inventory Turnover Ratio Ann.
-
-----
Asset Turnover Ann. %
-
-----
Working Capital Turnover Ann.
-
Quick Ratio Ann.
-
-0.20.12.810.7
Current Ratio Ann.
-
-0.30.1310.7
Interest Coverage Ratio Ann.
-
--73.60.7-22.6-25.1
LT Debt To Equity Ann.
-
-----
*All financials are in USD Million and price data in USD
Add metric to table
Search...

Tevogen Bio Holdings Inc cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Cash From Operating Activity Tevogen Bio Holdings Inc Cash From Operating Activity is $-12 Million which is growth of -2.7% YoY.

  • NEGATIVE

    Net Cash Flow Tevogen Bio Holdings Inc Net Cash Flow is $-1 Million which is growth of -416.8% YoY.

Tevogen Bio Holdings Inc., Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsDec '25Dec '24Dec '23Dec '22Dec '21
⌄
-
-12.3-12-1.4-8.7-5.3
⌄
-
-0.1342.9-0.5-0.1
⌄
16%
11.712.2-341.77.512.5
Cash Plus Cash Eqv. End Of Year Ann.
-52.2%
0.61.305.57.1
Net Increase In Cash Plus Cash Eqv.s Ann.
-
-0.70.2-0.1-1.67.1
Cash Plus Cash Eqv. Begin Of Year Ann.
-43.2%
1.31.10.17.1
Income Tax Paid Supplemental Data Ann.
-
-----
Interest Paid Supplemental Data Ann.
-
-----
Capex Ann.
-
-0.1---0.5-0.1
Issuance Of Capital Stock Ann.
-
4.911---
Issuance Of Debt Ann.
-23.2%
3.411.37.512.5
Repayment Of Debt Ann.
-
-----
Repurchase Of Capital Stock Ann.
-
---343--
Free Cash Flow Ann.
-
-12.4-12-1.4-9.1-5.4
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Cash from Financing Act. Ann.
1Y CHG
-4.1%
3Y CAGR
16%
×